Acute Otitis Media Treatment Market See Incredible Growth 2021-2028 | Pfizer, Inc., Eli Lilly and Company, Abbott Laboratories

Global Acute Otitis Media Treatment Market

The Global Acute Otitis Media Treatment Market, By Drug Type (Anesthetic, Analgesic, Antibiotics, and Non-steroidal anti-Inflammatory Drug), By Formulation (Topical and Oral), By Distribution Channel (Online Pharmacies, Hospitals, and Retail Pharmacies), and by Region (North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa) had a market valuation of US$ 2,043.3 million in 2016 and is anticipated to grow at a CAGR of 5.1 percent during the forecast period (2017 – 2025).

The increasing prevalence of acute otitis media is expected to be a major factor in the growth of the global acute otitis media treatment market. According to an article published in PLOS ONE Journal in 2012, the incidence of acute otitis media is about 10.9%, and about 709 million people suffer from this disease each year. Among them, children under 5 account for about 51%. It is expected that the increase in the prevalence of acute otitis media in children will lead to an increase in the demand for treatment.

To Get more Business Statergies Request for Sample Report at – https://www.coherentmarketinsights.com/insight/request-sample/1333

Browse 36 Market Data Tables and 42 Figures spread through 178 Pages and in-depth TOC on Global Acute Otitis Media Treatment Market by Drug Type (Anesthetic, Analgesic, Antibiotics, and Non-steroidal anti-Inflammatory Drug), By Formulation (Topical and Oral), By Distribution Channel (Online Pharmacies, Hospitals, and Retail Pharmacies), and by Region (North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa) - Global Forecast to 2025.

Major players in the global acute otitis media treatment market are focusing on launching multiple products. Laboratories SALVAT S.A. and Arbor Pharmaceuticals, LLC introduced OTOVEL and a solution for the treatment of acute otitis media. The increase in product approvals is another factor that is expected to contribute to the growth of the market. In 2017, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion on GlaxoSmithKline plc. The new four-dose vials of Synflorix pneumococcal vaccine are suitable for active immunization against acute otitis media. In 2013, Pfizer received European approval to expand the use of its Prevenar 13 (pneumococcal polysaccharide conjugate vaccine) for the prevention of invasive diseases, pneumonia and acute otitis media caused by streptococcal pneumonia in adults aged 18-49. In 2015, Otonomy, Inc.'s OTIPRIO (Otic Ciprofloxacin Suspension) for the treatment of AOM was approved by the U.S. Food and Drug Administration (FDA).

To Get Research PDF Brochure Here @ https://www.coherentmarketinsights.com/insight/request-pdf/1333

Key Takeaways

As regulatory agencies increasingly approve innovative products for the treatment of AOM, the global market for acute otitis media treatment is expected to grow at a compound annual growth rate of 5.1% over the period of forecast (2017-2025).

North America is the dominant region of the market and is expected to continue to dominate during the forecast period (2017-2025). This is due to the increasing prevalence of acute otitis media and the introduction of new drugs for the treatment of acute otitis media in the region.

Major players are focused on expanding their market share by launching new drugs and obtaining marketing approvals for new products in major regions.

Key companies contributing in the global acute otitis media treatment market are Bayer AG, Abbott Laboratories, Eli Lilly and Company, Sanofi S.A., Pfizer, Inc., Bristol Myers Squibb Company, Pediapharm Inc., GlaxoSmithKline plc., and Novartis AG.

To Direct Purchase this Research Report – https://www.coherentmarketinsights.com/insight/buy-now/1333

1. Overview and Scope

1.1. Research goal & scope

1.2. Research assumptions

1.3. Research methodology

1.3.1. Primary data sources

1.3.2. Secondary data sources

1.4. Key takeaway

1.5. Stakeholders

2. Executive Summary

2.1. Market definition

2.2. Market segmentation

3. Acute Otitis Media Treatment Market Insights

3.1. Acute Otitis Media Treatment - Industry snapshot

3.1.1. Leading Companies

3.1.2. Key Companies to Watch

3.2. Acute Otitis Media Treatment - Ecosystem analysis

3.2.1. Market overview

3.2.2. Commercial Landscape

3.3. Acute Otitis Media Treatment Market Dynamics

3.3.1. Market Forces

3.3.1.1. Market Driver Analysis

3.3.1.2. Market Restraint/Challenges analysis

3.3.1.3. Market Opportunity Analysis

3.4. Industry analysis – Porter’s five forces

3.4.1. Bargaining power of supplier

3.4.2. Bargaining power of the buyer

3.4.3. Threat of substitute

3.4.4. The threat of new entrant

3.4.5. Degree of competition

3.5. Market PEST Analysis

3.6. Market Value Chain Analysis

3.7. Industry Trends

3.8. Competitive Ranking Analysis

Contact Us:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

This release was published on openPR.